Doxylamine/pyridoxine delayed release 10 mg/10 mg

Pregnancy & gynaecology-specific. Every dose row is source-referenced; verify against institutional protocols.

Doxylamine/pyridoxine delayed release 10 mg/10 mgAntiemetic first-line NVP

Regimens checked: 2026-10-17. Each indication has its own preparation, limits and safety checks.

Doxylamine/pyridoxine delayed release 10 mg/10 mg: indication-specific regimens
Indication	Dose	Route	Frequency	Duration / preparation	Maximum	Monitoring / cautions
Nausea and vomiting of pregnancy: the cited product contains 10 mg/10 mg PER tablet Exeltis / emcchecked	Day 1: two tablets at bedtime. If inadequate: day 3 add one morning tablet; day 4 may add one mid-afternoon tablet	Oral delayed release	Daily scheduled dosing, not as-needed	Reassess during pregnancy; taper gradually when no longer needed · 10 mg doxylamine +10 mg pyridoxine gastro-resistant tablets: swallow whole with water on an empty stomach. Do not crush, split or substitute a different-strength combination	4 tablets/day: one morning, one mid-afternoon, two bedtime (40 mg/40 mg total)	Monitor Sedation, symptom control, ability to eat/drink; avoid driving if drowsy Contraindications / cautions MAO inhibitors; additive sedation with alcohol or other CNS depressants; breastfeeding requires product-specific advice

Pregnancy safety

Best-established first-line

Lactation

The cited Xonvea product does not recommend breastfeeding use; review the product and maternal need.